KM

Kunchitiga Manjula

Active Director Additional Director DIN 11139459
DIN 11139459 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunchitiga Manjula

Data last updated:

Kunchitiga Manjula is an Additional Director at Crinamed Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11139459
Primary Designation Additional Director
Industry Pharma
First Appointment 04 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director04 Jun 20252025Active

Directorship timeline

Open interactive timeline →
Crinamed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kunchitiga Manjula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunchitiga Manjula

Kunchitiga Manjula currently holds 1 directorship: Crinamed Pharmaceuticals Private Limited (Additional Director, since 04 Jun 2025).

Kunchitiga Manjula was first appointed on 04 Jun 2025 as Additional Director at Crinamed Pharmaceuticals Private Limited.

The current boards of Kunchitiga Manjula's companies include Jaleel Nijamuddin (Crinamed Pharmaceuticals Private Limited), Jayanthi Doddi Ambrish (Crinamed Pharmaceuticals Private Limited), Nallabathini Krishnareddy (Crinamed Pharmaceuticals Private Limited), Preethi Muninarayanappa (Crinamed Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available